The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
出版年份 2016 全文链接
标题
The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 16, Issue 3, Pages 245-258
出版商
Informa UK Limited
发表日期
2016-02-06
DOI
10.1586/14737175.2016.1150783
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mitochondrial Dysfunction in Parkinson's Disease
- (2017) Jianhui Zhu et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson’s Disease
- (2015) Pablo Martinez-Martin et al. CNS DRUGS
- Safinamide: First Global Approval
- (2015) Emma D. Deeks DRUGS
- Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease
- (2015) Mona Sadeghian et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis
- (2015) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Safinamide for the treatment of Parkinson's disease
- (2014) Livia Dézsi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Safinamide for the treatment of Parkinson’s disease
- (2014) Rukmini Mridula Kandadai et al. Expert Review of Clinical Pharmacology
- Rasagiline induced hypersexuality in Parkinson’s disease
- (2013) Dennys Reyes et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Disposition and Metabolism of Safinamide, a Novel Drug for Parkinson's Disease, in Healthy Male Volunteers
- (2013) Chiara Leuratti et al. PHARMACOLOGY
- Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor
- (2013) Samantha Podurgiel et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease
- (2012) Santiago Perez-Lloret et al. CLINICAL NEUROPHARMACOLOGY
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Safety of rasagiline for the treatment of Parkinson's disease
- (2011) Santiago Perez-Lloret et al. Expert Opinion On Drug Safety
- A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease
- (2010) Santiago Perez-Lloret et al. CNS DRUGS
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Dopamine agonist-based strategies in the treatment of Parkinson’s disease
- (2009) Angelo Antonini et al. NEUROLOGICAL SCIENCES
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- An expert opinion on safinamide in Parkinson's disease
- (2008) Marco Onofrj et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Chronic pain in Parkinson's disease: The cross-sectional French DoPaMiP survey
- (2008) Laurence Nègre-Pagès et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started